$PFTA
Perception Capital Corp III Stock $pfta

$pfta Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000182912624005933 Filed on August 29, 2024

Income Statement

Concept	2024 Q2
Revenue	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$570.4K
YoY Change	-37.32%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$570.4K
YoY Change	-37.32%
Operating Profit	-$570.4K
YoY Change	-37.08%
Interest Expense	$438.1K
YoY Change	-90.39%
% of Operating Profit
Other Income/Expense, Net	$847.6K
YoY Change	-82.75%
Pretax Income	$277.3K
YoY Change	-93.09%
Income Tax
% Of Pretax Income
Net Earnings	$277.3K
YoY Change	-93.08%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.03
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$131.8K
YoY Change	-99.95%
Cash & Equivalents	$131.8K
Short-Term Investments
Other Short-Term Assets	$88.49K
YoY Change	-11.51%
Inventory
Prepaid Expenses	$88.49K
Receivables
Other Receivables
Total Short-Term Assets	$220.3K
YoY Change	-59.1%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$42.55M
YoY Change	-84.19%
Other Assets
YoY Change
Total Long-Term Assets	$42.55M
YoY Change	-84.19%
TOTAL ASSETS
Total Short-Term Assets	$220.3K
Total Long-Term Assets	$42.55M
Total Assets	$42.77M
YoY Change	-84.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$2.025M
YoY Change	13.84%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$26.93M
YoY Change	789.11%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change
Other Long-Term Liabilities	$1.451M
YoY Change	141.89%
Total Long-Term Liabilities	$1.451M
YoY Change	141.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$26.93M
Total Long-Term Liabilities	$1.451M
Total Liabilities	$28.38M
YoY Change	680.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.257M
YoY Change	-71.72%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.256M
YoY Change
Total Liabilities & Shareholders Equity	$42.77M
YoY Change	-84.14%

Cashflow Statement

Concept	2024 Q2
OPERATING ACTIVITIES
Net Income	$277.3K
YoY Change	-93.08%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$173.7K
YoY Change	-83.62%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	50.00K
YoY Change	-96.0%
NET CHANGE
Cash From Operating Activities	-173.7K
Cash From Investing Activities
Cash From Financing Activities	50.00K
Net Change In Cash	-123.7K
YoY Change	-165.09%
FREE CASH FLOW
Cash From Operating Activities	-$173.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1592069
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3109 W 50th St
	dei	Entity Address City Or Town EntityAddressCityOrTown	Minneapolis
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55410
	dei	City Area Code CityAreaCode	(952)
CY2024Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-409561	usd
CY2024Q2	PFTAU	Promissory Note Outstanding PromissoryNoteOutstanding	0	usd
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001853580
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	PERCEPTION CAPITAL CORP. III
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
	dei	Entity File Number EntityFileNumber	001-40639
	dei	Local Phone Number LocalPhoneNumber	456-5300
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	131835	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	102925	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	88491	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	302339	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	220326	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	405264	usd
CY2024Q2	us-gaap	Assets Held In Trust AssetsHeldInTrust	42550517	usd
CY2023Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	41678895	usd
CY2024Q2	us-gaap	Assets Assets	42770843	usd
CY2023Q4	us-gaap	Assets Assets	42084159	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2025241	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1213065	usd
CY2024Q1	PFTAU	Accretion Of Class Ordinary Shares To Redemption Value AccretionOfClassOrdinarySharesToRedemptionValue	-433556	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	622961	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-3095433	usd
CY2023Q4	PFTAU	Ordinary Class Shares To Be Redeemed OrdinaryClassSharesToBeRedeemed		usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2024Q2	PFTAU	Reduction Of Deferred Underwriter Fees ReductionOfDeferredUnderwriterFees		usd
	PFTAU	Reduction Of Deferred Underwriter Fees ReductionOfDeferredUnderwriterFees		usd
CY2024Q2	PFTAU	Conversion Of Class B Ordinary Shares To Class Ordinary Shares ConversionOfClassBOrdinarySharesToClassOrdinaryShares		usd
	PFTAU	Reduction Of Deferred Underwriter Fees ReductionOfDeferredUnderwriterFees		usd
	PFTAU	Proceeds From Subscription Agreement Liability ProceedsFromSubscriptionAgreementLiability		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	PFTAU	Reduction Of Deferred Underwriting Fee Payable ReductionOfDeferredUnderwritingFeePayable		usd
	PFTAU	Common Stock To Be Redeemed CommonStockToBeRedeemed		usd
	PFTAU	Contribution Nonredemption Agreements ContributionNonredemptionAgreements		usd
	PFTAU	Fair Value Of Shareholder Nonredemption Agreement FairValueOfShareholderNonredemptionAgreement		usd
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity Address Address Line2 EntityAddressAddressLine2	#207
CY2024Q2	PFTAU	Ordinary Class Shares To Be Redeemed OrdinaryClassSharesToBeRedeemed	24906683	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	26931924	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1213065	usd
CY2024Q2	PFTAU	Subscription Agreement Liability SubscriptionAgreementLiability	1025000	usd
CY2023Q4	PFTAU	Subscription Agreement Liability SubscriptionAgreementLiability	650000	usd
CY2024Q2	us-gaap	Extended Product Warranty Accrual Noncurrent ExtendedProductWarrantyAccrualNoncurrent	426308	usd
CY2023Q4	us-gaap	Extended Product Warranty Accrual Noncurrent ExtendedProductWarrantyAccrualNoncurrent	1827037	usd
CY2024Q2	us-gaap	Liabilities Liabilities	28383232	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3690102	usd
CY2024Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	17643834	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	41678895	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3256871	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3285486	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-3256223	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-3284838	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42770843	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42084159	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	570351	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	906500	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1372114	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1496934	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-570351	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-906500	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1372114	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1496934	usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1370278	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1400729	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2436050	usd
CY2023Q2	PFTAU	Reduction Of Deferred Underwriter Fees ReductionOfDeferredUnderwriterFees	352969	usd
	PFTAU	Reduction Of Deferred Underwriter Fees ReductionOfDeferredUnderwriterFees	352969	usd
CY2024Q2	us-gaap	Interest Revenue Expense Net InterestRevenueExpenseNet	438066	usd
CY2023Q2	us-gaap	Interest Revenue Expense Net InterestRevenueExpenseNet	3191741	usd
	us-gaap	Interest Revenue Expense Net InterestRevenueExpenseNet	871622	usd
	us-gaap	Interest Revenue Expense Net InterestRevenueExpenseNet	5939100	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	847627	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4914988	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2272351	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8728119	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	277276	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4008488	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	900237	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7231185	usd
CY2024Q2	PFTAU	Weighted Average Class Ordinary Shares Outstanding Basic And Diluted WeightedAverageClassOrdinarySharesOutstandingBasicAndDiluted	3859528	shares
CY2023Q2	PFTAU	Weighted Average Class Ordinary Shares Outstanding Basic And Diluted WeightedAverageClassOrdinarySharesOutstandingBasicAndDiluted	25911379	shares
	PFTAU	Weighted Average Class Ordinary Shares Outstanding Basic And Diluted WeightedAverageClassOrdinarySharesOutstandingBasicAndDiluted	3885090	shares
	PFTAU	Weighted Average Class Ordinary Shares Outstanding Basic And Diluted WeightedAverageClassOrdinarySharesOutstandingBasicAndDiluted	25911379	shares
CY2024Q2	PFTAU	Basic And Diluted Net Income Per Ordinary Share Redeemable BasicAndDilutedNetIncomePerOrdinaryShareRedeemable	0.03
CY2023Q2	PFTAU	Basic And Diluted Net Income Per Ordinary Share Redeemable BasicAndDilutedNetIncomePerOrdinaryShareRedeemable	0.12
	PFTAU	Basic And Diluted Net Income Per Ordinary Share Redeemable BasicAndDilutedNetIncomePerOrdinaryShareRedeemable	0.09
	PFTAU	Basic And Diluted Net Income Per Ordinary Share Redeemable BasicAndDilutedNetIncomePerOrdinaryShareRedeemable	0.22
CY2024Q2	PFTAU	Weighted Average Class B Ordinary Shares Outstanding Basic And Diluted WeightedAverageClassBOrdinarySharesOutstandingBasicAndDiluted	6477845	shares
CY2023Q2	PFTAU	Weighted Average Class B Ordinary Shares Outstanding Basic And Diluted WeightedAverageClassBOrdinarySharesOutstandingBasicAndDiluted	6477845	shares
	PFTAU	Weighted Average Class B Ordinary Shares Outstanding Basic And Diluted WeightedAverageClassBOrdinarySharesOutstandingBasicAndDiluted	6477845	shares
	PFTAU	Weighted Average Class B Ordinary Shares Outstanding Basic And Diluted WeightedAverageClassBOrdinarySharesOutstandingBasicAndDiluted	6477845	shares
CY2024Q2	PFTAU	Basic And Diluted Net Income Per Ordinary Share Nonredeemable BasicAndDilutedNetIncomePerOrdinaryShareNonredeemable	0.03
CY2023Q2	PFTAU	Basic And Diluted Net Income Per Ordinary Share Nonredeemable BasicAndDilutedNetIncomePerOrdinaryShareNonredeemable	0.12
	PFTAU	Basic And Diluted Net Income Per Ordinary Share Nonredeemable BasicAndDilutedNetIncomePerOrdinaryShareNonredeemable	0.09
	PFTAU	Basic And Diluted Net Income Per Ordinary Share Nonredeemable BasicAndDilutedNetIncomePerOrdinaryShareNonredeemable	0.22
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-3284838	usd
CY2024Q2	PFTAU	Accretion Of Class Ordinary Shares To Redemption Value AccretionOfClassOrdinarySharesToRedemptionValue	-438066	usd
CY2024Q2	PFTAU	Contribution Nonredemption Agreement ContributionNonredemptionAgreement	2042132	usd
CY2024Q2	PFTAU	Fair Value Of Shareholder Nonredemption Agreements FairValueOfShareholderNonredemptionAgreements	-2042132	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	277276	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-3256223	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-6577830	usd
CY2023Q1	PFTAU	Accretion Of Class Ordinary Shares To Redemption Value AccretionOfClassOrdinarySharesToRedemptionValue	-2747359	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	3222697	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-6102492	usd
CY2023Q2	PFTAU	Accretion Of Class Ordinary Shares To Redemption Value AccretionOfClassOrdinarySharesToRedemptionValue	-3191741	usd
CY2023Q2	PFTAU	Reduction Of Deferred Underwriter Fee ReductionOfDeferredUnderwriterFee	2186346	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	4008488	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3099399	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	900237	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7231185	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	871622	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	5939100	usd
	PFTAU	Change In Fair Value Of Warrant Liabilities ChangeInFairValueOfWarrantLiabilities	1400729	usd
	PFTAU	Change In Fair Value Of Warrant Liabilities ChangeInFairValueOfWarrantLiabilities	2436050	usd
	PFTAU	Reduction Of Deferred Underwriter Fees ReductionOfDeferredUnderwriterFees	352969	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-213848	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-392136	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	812176	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-80122	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-346090	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1184920	usd
	PFTAU	Proceeds From Subscription Agreement Liability ProceedsFromSubscriptionAgreementLiability	375000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1250000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	375000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1250000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	28910	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	65080	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	102925	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	368687	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	131835	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	433767	usd
	PFTAU	Remeasurement Of Class Ordinary Shares To Redemption Value RemeasurementOfClassOrdinarySharesToRedemptionValue	871622	usd
	PFTAU	Remeasurement Of Class Ordinary Shares To Redemption Value RemeasurementOfClassOrdinarySharesToRedemptionValue	5939100	usd
	PFTAU	Reduction Of Deferred Underwriting Fee Payable ReductionOfDeferredUnderwritingFeePayable	2539315	usd
	PFTAU	Common Stock To Be Redeemed CommonStockToBeRedeemed	24906683	usd
	PFTAU	Contribution Nonredemption Agreements ContributionNonredemptionAgreements	2042132	usd
	PFTAU	Fair Value Of Shareholder Nonredemption Agreement FairValueOfShareholderNonredemptionAgreement	-2042132	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_803_eus-gaap--NatureOfOperations_zx604vTwiui5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 1. <span id="xdx_82C_zZ4vI9lXIXEg">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0.5in">Perception Capital Corp. III (the “Company” or “PC3”) is a blank check company incorporated in the Cayman Islands on March 17, 2021. Effective October 11, 2023, the Company changed its name from “Portage Fintech Acquisition Corporation.” The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">As of June 30, 2024, the Company had not yet commenced any operations. All activity for the period March 17, 2021 (inception) through June 30, 2024 relates to the Company’s formation, the initial public offering (the “Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the securities and cash held in the Trust Account. The Company has selected December 31 as its fiscal year end.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0.5in">The Company’s initial sponsor was PFTA I LP, an Ontario limited partnership (the “Initial Sponsor”). On July 21, 2023, the Initial Sponsor sold a portion of its Class B ordinary shares and Private Placement Warrants (defined below) to Perception Capital Partners IIIA LLC, a Delaware limited liability company (the “Managing Sponsor”), pursuant to a Securities Purchase Agreement dated July 12, 2023 (the “Purchase Agreement”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0.5in">The registration statement for the Company’s Initial Public Offering was declared effective by the Securities and Exchange Commission (the “SEC”) on July 20, 2021. On July 23, 2021, the Company consummated its Initial Public Offering of <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210701__20210723__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Sale of units in initial public offering">24,000,000</span> units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), at $<span id="xdx_90B_eus-gaap--SaleOfStockPricePerShare_c20210723__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Sale of units per share">10.00</span> per Unit, generating gross proceeds of $<span id="xdx_90E_ecustom--SaleOfUnitsInInitialPublicOfferingAggragateAmount_pn3n3_dm_c20210701__20210723__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zpQtK7qKos45" title="Sale of units in initial public offering aggragate amount">240.0</span> million.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0.5in">The Company incurred offering costs in the Initial Public Offering totaling $<span id="xdx_90B_ecustom--OfferingCosts_pp0p0_c20210701__20210723__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zSPmUTRusEOg" title="Offering costs">14,355,016</span>, consisting of $<span id="xdx_900_ecustom--UnderwritingFees_pp0p0_c20210701__20210723__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zfInJV2kxvk6" title="Underwriting fees">4,800,000</span> of underwriting fees, $<span id="xdx_902_ecustom--DeferredUnderwritingFees_pp0p0_c20210701__20210723__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zl07E7eVR9bk" title="Deferred underwriting fees">8,400,000</span> of deferred underwriting fees, and $<span id="xdx_90B_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_pp0p0_c20210701__20210723__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zhNN9rVixBzb" title="Other Offering costs">1,155,016</span> of other offering costs (see Note 2).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0.5in">Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210701__20210723__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Sale of units in initial public offering">6,333,334</span> warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $<span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_c20210723__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Sale of units per share">1.50</span> per Private Placement Warrant with the Initial Sponsor, generating gross proceeds of $<span id="xdx_903_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20210701__20210723__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zhOfMtNM7DE8" title="Sale of units in initial public offering aggragate amount">9,500,000</span> (see Note 4 and Note 8).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0.5in">Upon the closing of the Initial Public Offering and the Private Placement, an amount of $<span id="xdx_90E_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_dm_c20210701__20210723__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zsxAycUBAQL9" title="Sale of units in initial public offering aggragate amount">240.0</span> million ($<span id="xdx_90A_eus-gaap--SaleOfStockPricePerShare_iI_c20210723__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zJaYjByUQ8Rd" title="Sale of units per share">10.00</span> per Unit) from the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee and invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”) having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0.5in">On August 3, 2021, the underwriters notified the Company of their intention to partially exercise the over-allotment option on August 5, 2021 (the “Over-Allotment”). As such, on August 5, 2021, the Company consummated the sale of an additional <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210801__20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z0WFfuiQDT88" title="Sale of units in initial public offering">1,911,379</span> Units (the “Over-Allotment Units”), at $<span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_c20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zhDqWr2srZU2" title="Sale of units per share">10.00</span> per Unit, and the sale of an additional <span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210801__20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zytFkc1wNz9i" title="Sale of units in initial public offering">254,850</span> Private Placement Warrants, at $1.50 per Private Placement Warrant, generating total gross proceeds of $<span id="xdx_903_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20210801__20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z8DWoYRp3zAi" title="Sale of units in initial public offering aggragate amount">19,113,790</span> and $<span id="xdx_904_ecustom--UnderwritingFees_pp0p0_c20210801__20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z67DClG25P16" title="Underwriting fees">382,275</span>, respectively. The underwriters forfeited the balance of the over-allotment option. A total of $<span id="xdx_901_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20210801__20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zNlYULNXQDjh" title="Sale of units in initial public offering aggragate amount">19,113,790</span> of the net proceeds was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pp0p0_c20210801__20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zNzgwtFU9dSb" title="Proceeds from private placement">259,113,790</span> (see Note 2). The Company incurred additional offering costs of $<span id="xdx_909_ecustom--OfferingCosts_pp0p0_c20210801__20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zIFjuN8Ad5Wj" title="Offering costs">1,051,258</span> in connection with the Over-Allotment (of which $<span id="xdx_904_ecustom--DeferredUnderwritingFees_pp0p0_c20210801__20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z6VzlyT3Art" title="Deferred underwriting fees">668,983</span> was for deferred underwriting fees).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0.5in">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds, which are placed in the Trust Account, are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more target businesses that together have a fair market value equal to at least <span id="xdx_90D_ecustom--PercentageOfAssetHeldInTrustAccount_dp_c20240101__20240630_z5QzxsLg9ma" title="Percentage of asset held in trust account">80</span>% of the balance held in the Trust Account (less any deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-Business Combination company owns or acquires <span id="xdx_903_ecustom--BusinessCombinationPercentageOfVotingSecurities_iI_dp_c20240630_zY01IMxN4Pl1" title="Business combination, percentage of voting securities">50</span>% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0.5in">The Company will provide its holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination pursuant to the proxy solicitation rules of the SEC or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company will be required to seek shareholder approval of a Business Combination at a meeting called for such purpose at which shareholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $<span id="xdx_902_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_pp0p0_c20240630_zOoUQjtvvQY9" title="Business Combination, minimum amount of net tangible assets">5,000,001</span> either immediately prior to or upon such consummation of a Business Combination and a majority of the outstanding shares voted are voted in favor of the Business Combination.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Notwithstanding the foregoing, the Company’s amended and restated memorandum and articles of association (as amended, the “Articles”) provide that, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 15% or more of the Public Shares without the Company’s prior written consent.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0.5in">The Public Shareholders will be entitled to redeem their shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to shareholders who redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. These Public Shares are recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; text-indent: 0.5in">If the Company is not required to conduct redemptions pursuant to the proxy solicitation rules as described above, the Company will, pursuant to its Articles, offer such redemption pursuant to the tender offer rules of the SEC, and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; text-indent: 0.5in">Pursuant to an amended and restated letter agreement dated July 21, 2023 (the “Letter Agreement”), the Company’s sponsors and current and former officers, directors and certain advisors have agreed (a) to vote their Founder Shares (as defined in Note 8) and any Public Shares purchased during or after the Initial Public Offering in favour of a Business Combination, (b) not to redeem any shares (including the Founder Shares) into the right to receive cash from the Trust Account in connection with a shareholder vote to approve a Business Combination or a vote to amend the provisions of the Articles relating to shareholders’ rights of pre-Business Combination activity and (c) that the Founder Shares shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the above-listed parties to the Letter Agreement will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">On July 21, 2023, the Company held an extraordinary general meeting of shareholders (the “First Extension Meeting”). At the First Extension Meeting, the Company’s shareholders approved two proposals to amend the Company’s amended and restated memorandum and articles of association (the “Articles”). The first such proposal (the “Extension Amendment” and, such proposal, the “Extension Amendment Proposal”) sought to amend the Articles to extend the date by which the Company must (1) consummate a Business Combination, (2) cease its operations except for the purpose of winding up if it fails to complete a Business Combination, and (3) redeem all of the Company’s Class A ordinary shares sold in the Company’s IPO, from 24 months from the closing of the IPO to 36 months from the closing of the IPO or such earlier date as is determined by our board of directors (the “Board”) to be in the best interests of the Company. The second such proposal (the “Redemption Limitation Amendment” and such proposal, the “Redemption Limitation Amendment Proposal”) sought to eliminate from the Articles the limitation that the Company shall not redeem Class A ordinary shares sold in the IPO to the extent that such redemption would cause the Company’s net tangible assets to be less than $<span id="xdx_90B_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_pp0p0_c20240630_zayiCfV1T7S2" title="Business Combination, minimum amount of net tangible assets">5,000,001</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; text-indent: 0.5in">In connection with the vote to approve the Extension Amendment Proposal, effective as of July 21, 2023, holders of <span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_c20230721__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_pdd" title="Common stock shares authorized">22,001,009</span> Class A ordinary shares exercised their right to redeem their shares for cash at a redemption price of approximately $<span id="xdx_900_eus-gaap--SharePrice_c20230721__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_pdd" title="Share price">10.41</span> per share, for an aggregate redemption amount of approximately $<span id="xdx_906_ecustom--AggregateRedemptionAmount_iI_pn3n3_dm_c20230721__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zM9XLubufFpf" title="Aggregate redemption amount">229.1</span> million. As a result, approximately $<span id="xdx_90D_eus-gaap--AssetsHeldInTrust_iI_pn3n3_dm_c20230721__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zgifEJIkIqT8" title="Trust account">40.7</span> million remained in the Company’s trust account as of July 21, 2023 and <span id="xdx_902_ecustom--OutstandingShares_c20230721__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_pdd" title="Outstanding shares">3,910,370</span> Class A ordinary shares remained outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; text-indent: 0.5in">On October 11, 2023, the Company held an extraordinary general meeting of shareholders (the “Meeting”) at which shareholders approved changing the name of the Company from “Portage Fintech Acquisition Corporation” to “Perception Capital Corp. III” (the “Name Change”) and the amendment and restatement of the Company’s amended and restated memorandum and articles of association to reflect the Name Change (the “Articles Amendment”). The Name Change and the Articles Amendment did not alter the voting powers or relative rights of the Company’s ordinary shares. The Articles Amendment was filed with the Cayman Islands Registrar of Companies on October 11, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: justify; margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; text-indent: 0.5in">On February 6, 2024, the Company entered into a business combination agreement (the “Business Combination Agreement” or “BCA”) with RBio Energy Holdings Corp., a Delaware corporation and a wholly owned subsidiary of PC3 (“NewPubco”), Perception RBio Merger Sub, a Cayman Islands exempted company and a wholly owned subsidiary of NewPubco (“Merger Sub”), and RBio Energy Corporation, a Delaware corporation (“RBio Energy”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">On February 6, 2024, the Company received a notice (the “Notice”) from the Listing Qualifications Department of Nasdaq stating that the Company had failed to hold an annual meeting of shareholders within 12 months after our fiscal year end, as required by Nasdaq Listing Rule 5620(a) (the “Annual Shareholders Meeting Rule”) and therefore was not in compliance with the Annual Shareholders Meeting Rule. The Notice stated that the Company had 45 calendar days, or until March 25, 2024, to submit a plan to regain compliance with the Annual Shareholders Meeting Rule. On March 19, 2024, the Company submitted to Nasdaq a plan to regain compliance with the Annual Shareholders Meeting Rule within the required timeframe. On April 15, 2024, Nasdaq accepted the Company’s plan and granted the Company an extension until June 30, 2024 to regain compliance with the Annual Shareholders Meeting Rule.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">On June 28, 2024, the Company held its second extraordinary general meeting in lieu of annual meeting of shareholders (the “Second Extension Meeting”) at which its shareholders approved a proposal to amend the Articles to extend the date by which the Company has to consummate a business combination from July 23, 2024 to April 23, 2025, or such earlier date as may be determined by the Company’s board of directors to be in the best interests of the Company (the “Second Extension Amendment” and such later date, the “Extended Date”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">In connection with the votes to approve the proposal above, the holders of <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20240628__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zkHvIXtQO5Z7" title="Common stock shares authorized">2,287,870</span> Class A Ordinary Shares of the Company properly exercised their right to redeem their shares for cash at a redemption price of approximately $<span id="xdx_90D_eus-gaap--SharePrice_iI_c20240628__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zQ8hQIMTkpOh" title="Share price">10.89</span> per share, for an aggregate redemption amount of approximately $<span id="xdx_90F_ecustom--AggregateRedemptionAmount_iI_pn3n3_dm_c20240628__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zip7vwgmf5Wk" title="Aggregate redemption amount">24.9</span> million, leaving approximately $<span id="xdx_90D_eus-gaap--AssetsHeldInTrust_iI_pn3n3_dm_c20240628__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_z0Qc40i26UCf" title="Trust account">17.7</span> million in the trust account.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">In connection with the implementation of the Second Extension Amendment, the Sponsor and PFTA 1 LP, the former sponsor, converted an aggregate of <span id="xdx_907_ecustom--OutstandingShares_iI_c20240628__us-gaap--StatementClassOfStockAxis__custom--ClassBOrdinarySharesMember_zsTQBYt6bD86" title="Outstanding shares">6,322,845</span> Class B Ordinary Shares into <span id="xdx_901_ecustom--OutstandingShares_iI_c20240628__us-gaap--StatementClassOfStockAxis__custom--ClassAOrdinarySharesMember_zyzBVetlDVp1" title="Outstanding shares">6,322,845</span> Class A Ordinary Shares (the “Class B Conversion”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">As a result of holding its extraordinary general meeting in lieu of annual meeting on June 28, 2024 within Nasdaq’s extended timeframe, the Company regained compliance with the Annual Shareholders Meeting Rule.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">On July 23, 2024, the Company received a notice from the staff of the Listing Qualifications Department of Nasdaq indicating that unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”), trading of the Company’s securities on Nasdaq would be suspended at the opening of business on August 1, 2024, due to the Company’s non-compliance with Nasdaq IM-5101-2, which requires that a special purpose acquisition company complete one or more business combinations within 36 months of the effectiveness of its registration statement in connection with its initial public offering.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The Company timely requested a hearing before the Panel to request sufficient time to complete its previously disclosed proposed business combination with RBio Energy Corporation (“RBio”). The hearing request resulted in a stay of any suspension or delisting action pending the hearing, which is scheduled for August 29, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">There can be no assurance that the Company will be able to satisfy Nasdaq’s continued listing requirements, regain compliance with Nasdaq IM-5101-2, and maintain compliance with other Nasdaq listing requirements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">If the Company is unable to complete a Business Combination by April 23, 2025 (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes (less up to $<span id="xdx_90B_ecustom--TaxObligationAmountMaximum_iI_pp0p0_c20240630_zDvtNQx5CoId" title="Tax obligation, maximum amount">100,000</span> of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to the requirements of applicable law, including any obligations to provide for claims of creditors. The underwriters have agreed to waive their rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period, and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit $10.00.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0.5in">Pursuant to the Letter Agreement, the Managing Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Managing Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Managing Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Managing Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure its shareholders that the Managing Sponsor would be able to satisfy those obligations. Neither the Initial Sponsor nor any of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Managing Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Going Concern, Liquidity and Management’s Plans</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">As of June 30, 2024, the Company had $<span id="xdx_906_eus-gaap--Cash_iI_pp0p0_c20240630_zJVl23iDbxK8" title="Operating bank account">131,835</span> in its operating bank account and working capital deficit of $<span id="xdx_905_ecustom--WorkingCapital_iI_pp0p0_c20240630_zE19KSH2Jeg9" title="Working Capital">1,804,915</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0.5in">The Company has principally financed its operations from inception using proceeds from the sale of its equity securities to its shareholders prior to the Initial Public Offering and such amount of proceeds from the Private Placement that were placed in an account outside of the Trust Account for working capital purposes. Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company may need to raise additional capital through loans or additional investments from its sponsors, shareholders, officers, directors, or third parties. The Company’s officers, directors and sponsors may, but are not obligated to (other than as described above), loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s (“FASB”) ASC Subtopic 205-40, “Presentation of Financial Statements - Going Concern,” the Company has until April 23, 2025 to consummate a Business Combination. It is uncertain whether the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, raises substantial doubt about the Company’s ability to continue as a going concern through approximately one year from the date these unaudited financial statements were issued. Management intends to consummate a Business Combination prior to April 23, 2025. These unaudited financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Risks and Uncertainties</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. These financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Various social and political circumstances in the U.S. and around the world (including wars and other forms of conflict, including rising trade tensions between the United States and China, and other uncertainties regarding actual and potential shifts in the U.S. and foreign, trade, economic and other policies with other countries, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility and economic uncertainties or deterioration in the U.S. and worldwide. Specifically, the rising conflict in the Middle East and between Russia and Ukraine, and resulting market volatilities could adversely affect the Company’s ability to complete a Business Combination. In response to the conflict between Russia and Ukraine, the U.S. and other countries have imposed sanctions or other restrictive actions against Russia. Any of the above factors, including sanctions, export controls, tariffs, trade wars and other governmental actions, could have a material adverse effect on the Company’s ability to complete a Business Combination and the value of the Company’s securities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
	PFTAU	Percentage Of Asset Held In Trust Account PercentageOfAssetHeldInTrustAccount	0.80	pure
CY2024Q2	PFTAU	Business Combination Percentage Of Voting Securities BusinessCombinationPercentageOfVotingSecurities	0.50	pure
CY2024Q2	us-gaap	Business Combination Contingent Consideration Asset BusinessCombinationContingentConsiderationAsset	5000001	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Asset BusinessCombinationContingentConsiderationAsset	5000001	usd
CY2024Q2	PFTAU	Tax Obligation Amount Maximum TaxObligationAmountMaximum	100000	usd
CY2024Q2	us-gaap	Cash Cash	131835	usd
CY2024Q2	PFTAU	Working Capital WorkingCapital	1804915	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_zs7fPOZeaw4b" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_863_zGdx77DgbHEa">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	131835	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	102925	usd
	PFTAU	Payments For Redemptions Of Class Ordinary Shares PaymentsForRedemptionsOfClassOrdinaryShares	229119437	usd
	PFTAU	Dissolution Expense DissolutionExpense	100000	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zL0nt0sA9oe1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_863_z5MmZz4RKkwc">Concentration of Credit Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution, which at times may exceed the Federal Depository Insurance Corporation coverage limit of $<span id="xdx_902_eus-gaap--CashFDICInsuredAmount_c20240630_pp0p0" title="FDIC Insured limit">250,000</span>. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q3	us-gaap	Legal Fees LegalFees	1483584	usd
CY2023Q3	us-gaap	Interest Paid InterestPaid	150000	usd
	PFTAU	Forgiveness Of Debt ForgivenessOfDebt	1333584	usd
	PFTAU	Debt Forgiven By Initial Sponsor DebtForgivenByInitialSponsor	150000	usd
CY2023Q2	PFTAU	Working Capital Expenses WorkingCapitalExpenses	1250000	usd
CY2023Q2	PFTAU	Promissory Note PromissoryNote	1250000	usd
CY2023Q3	PFTAU	Outstanding Amount OutstandingAmount	1250000	usd
	PFTAU	Forgiveness Of Debt From Initial Sponsor Pfta I Lp ForgivenessOfDebtFromInitialSponsorPftaILp	1487092	usd
CY2023Q3	PFTAU	Extension Shares ExtensionShares	650000	shares
CY2023Q4	PFTAU	Promissory Note Outstanding PromissoryNoteOutstanding	0	usd
CY2023Q2	PFTAU	Working Capital Expenses WorkingCapitalExpenses	1250000	usd
CY2023Q2	PFTAU	Promissory Note PromissoryNote	1250000	usd
	PFTAU	Related Party Loans Description RelatedPartyLoansDescription	The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $1.50 per warrant. The warrants will be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of June 30, 2024 and December 31, 2023, there were no amounts outstanding under the Working Capital Loans.
CY2021Q3	PFTAU	Pre Initial Public Offering Expenses PreInitialPublicOfferingExpenses	900000	usd
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	900000	usd
CY2024Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	0	usd
CY2023Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	229000	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	0	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	457000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	0	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	0	usd
CY2022Q3	us-gaap	Other Income OtherIncome	298484	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	6231184	usd
CY2023Q2	us-gaap	Other Income OtherIncome	352969	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	2186346	usd
CY2024Q2	PFTAU	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	0	usd
CY2023Q4	PFTAU	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	0	usd
	PFTAU	Non Redemption Agreement Discription NonRedemptionAgreementDiscription	In exchange for the foregoing commitment to the Company to not redeem the Non-Redeemed Shares, the Company anticipates agreeing to issue, or cause to be issued, to such shareholders, for every 200,000 Non-Redeemed Shares, 40,000 Class A ordinary shares for the first six months of extension, and 8,000 additional Class A ordinary shares for each additional month of extension, up to three additional months (such shares, the “Promote Shares”), upon closing of the initial business combination, and the Sponsor anticipates agreeing to surrender and forfeit, for no consideration, a number of Class B ordinary shares, par value $0.0001 per share, of the Company equal to the number of Promote Shares upon closing of the initial business combination.
	PFTAU	Fair Value Of Shareholder Nonredemptions Agreement FairValueOfShareholderNonredemptionsAgreement	2042132	usd
	PFTAU	Weighted Average Per Share WeightedAveragePerShare	8.57
CY2023Q3	PFTAU	Transaction Fee TransactionFee	2000000.0	usd
CY2023Q3	PFTAU	Gross Proceeds From Investors GrossProceedsFromInvestors	3000000	usd
CY2023Q3	PFTAU	Advisor Fee AdvisorFee	1000000	usd
CY2023Q3	PFTAU	Aggregate Amount AggregateAmount	1300000	usd
CY2023Q3	PFTAU	Initial Subscription Agreement InitialSubscriptionAgreement	650000	usd
CY2023Q3	PFTAU	Initial Business Combination InitialBusinessCombination	325000	usd
CY2023Q3	PFTAU	Initial Business Combination InitialBusinessCombination	325000	usd
CY2023Q3	PFTAU	Additional Fund AdditionalFund	200000	usd
CY2024Q2	PFTAU	Subscription Agreement Liability SubscriptionAgreementLiability	1025000	usd
CY2023Q4	PFTAU	Subscription Agreement Liability SubscriptionAgreementLiability	650000	usd
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	PFTAU	Founder Shares FounderShares	900000	shares
	PFTAU	Share Redemption Price Per Share ShareRedemptionPricePerShare	18.00
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
	PFTAU	Description Of Assets Held In Trust Account DescriptionOfAssetsHeldInTrustAccount	assets held in the Trust Account were comprised of $42,550,517 and $41,678,895, respectively, in cash and $0 in U.S. Treasury securities or money market funds. Through June 30, 2024, the trustee withdrew $229,119,437 from the Trust Account in connection with redemptions.
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0103	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.212	pure
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	11.50

Files In Submission

Name	View Source	Status
0001829126-24-005933-index-headers.html	Edgar Link	pending
0001829126-24-005933-index.html	Edgar Link	pending
0001829126-24-005933.txt	Edgar Link	pending
0001829126-24-005933-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
perceptioncapital3_10q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
perceptioncapital3_ex10-2.htm	Edgar Link	pending
perceptioncapital3_ex10-3.htm	Edgar Link	pending
perceptioncapital3_ex31-1.htm	Edgar Link	pending
perceptioncapital3_ex31-2.htm	Edgar Link	pending
perceptioncapital3_ex32-1.htm	Edgar Link	pending
perceptioncapital3_ex32-2.htm	Edgar Link	pending
pftau-20240630.xsd	Edgar Link	pending
pftau-20240630_cal.xml	Edgar Link	unprocessable
pftau-20240630_def.xml	Edgar Link	unprocessable
perceptioncapital3_10q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
pftau-20240630_pre.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
pftau-20240630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PFTA
Perception Capital Corp III Stock $pfta

2024 Q2 Form 10-Q Financial Statement

#000182912624005933 Filed on August 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PFTA Perception Capital Corp III Stock $pfta

2024 Q2 Form 10-Q Financial Statement

#000182912624005933 Filed on August 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PFTA
Perception Capital Corp III Stock $pfta